chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She still feels bad, but eventually she's feeling a little better everyday; feeling sick; Loss of appetite; lost of taste; she's not getting the second dose/ will not receive second vaccine; felt like throwing up; headache; muscle pain; chills; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (She still feels bad, but eventually she's feeling a little better everyday), MALAISE (feeling sick), DECREASED APPETITE (Loss of appetite), AGEUSIA (lost of taste) and PRODUCT DOSE OMISSION ISSUE (she's not getting the second dose/ will not receive second vaccine) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (She still feels bad, but eventually she's feeling a little better everyday), MALAISE (feeling sick), DECREASED APPETITE (Loss of appetite), AGEUSIA (lost of taste), PRODUCT DOSE OMISSION ISSUE (she's not getting the second dose/ will not receive second vaccine), NAUSEA (felt like throwing up), HEADACHE (headache), MYALGIA (muscle pain) and CHILLS (chills). The patient was treated with PREDNISONE at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (She still feels bad, but eventually she's feeling a little better everyday) was resolving, MALAISE (feeling sick), DECREASED APPETITE (Loss of appetite), AGEUSIA (lost of taste), NAUSEA (felt like throwing up), HEADACHE (headache), MYALGIA (muscle pain) and CHILLS (chills) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (she's not getting the second dose/ will not receive second vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant products included blood pressure and diabetes medications. Treatment information included an antibiotic.   Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2021: Updated the event(will not receive the second vaccine).; Sender's Comments: This case concerns a 73-year-old female patient who received the first dose of mRNA-1273 vaccine and will not receive second vaccine (product dose omission issue).  The other events are temporarily associated with the administration of the product and causal association cannot be excluded.  Product dose omission is assessed as not applicable
Pt recv vax on 2/26/98; on 3/3/98 pt exp petechiae around eyes & chin, flu-like sxs, vomitting; dx=flu, complicated by severe vomitting
Case received via the literature on 19-JUL-2010. A 15.5 week pregnant female received H1N1 influenza monovalent + thimerosal vaccine (manufacture unknown) on 22-OCT-2009. Prior to this, her pregnancy was uneventful. Two days after H1N1 immunization, she experienced cramping. One day after that, she experienced extreme pain. On 29-Oct-2009, she miscarried. No further information is available. This was originally received from Merck & Co., Inc. (case# 1007USA00149). The company considered this case serious due to medical significance and events possible to H1N1 vaccination, however brand of vaccine is unknown. Information derived from this AE does not change the current safety profile of the product.
headache/Headache was reported as worsened; rapid heart rate; arm hurt; This is a spontaneous report from a contactable consumer (patient).   A 34-years-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: UNKNOWN, Expiration date: UNKNOWN), via an unspecified route of administration on 22Dec2020 at 10:00 (at the age of 34-years-old) as 1ST DOSE, SINGLE in the left arm for covid-19 immunization. Patient medical history included patient tested positive for COVID-19 on 09Sep2021, patient had loss of taste and smell; next day horrible diarrhea; third day she had a headache for two days; then on day four or five she got a slight fever. The whole time starting on day three her heart was racing and she couldn't sleep. States her rapid heart rate was resolved about two weeks before the vaccine. She was still recovering her sense of taste. Mentioned she saw a cardiologist and had an echocardiogram that was normal (On an unknown date in 2021). She has continued to experience the episodes of resting tachycardia but not so often now. Maybe once every two weeks. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 22Dec2020, the patient experienced a headache and rapid heart rate that night and was up all night and headache reported as worsened. Patient mentioned that she previously had COVID-19 infection in Sep2020. Some of how it hit her, like the resting tachycardia, it seemed like some of her COVID symptoms came back that first night. Patient arm hurt but she felt like that was related to the administration of the shot. Patient states that her COVID symptoms had all gone away and then they came back but only for that first night after the first dose. At the time of this report event pain in arm was recovered on 25Dec2021, heart rate increased was recovering and the event headache aggravated was not recovered.    Follow-up attempts are completed. No further information is expected.
This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Huge improvements from Rheumatory Arthritis after 2nd dose//Huge improvements in RA lab numbers after 2nd dose) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 030L20A) for COVID-19 vaccination.     Previously administered products included for RA: Methotrexate (Patient stopped Methotrexate in 2018 because she had cancer) in 2018, Leflunomide (Prior to vaccination. she stopped Leflunomide and in AUG2020) until August 2020. Past adverse reactions to the above products included No adverse event with Leflunomide and Methotrexate. Concurrent medical conditions included Rheumatoid arthritis (Patient  was diagnosed with RA in 2014) since 2014 and Cancer.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Huge improvements from Rheumatory Arthritis after 2nd dose//Huge improvements in RA lab numbers after 2nd dose). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (Huge improvements from Rheumatory Arthritis after 2nd dose//Huge improvements in RA lab numbers after 2nd dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Rheumatological examination: normal (normal) zero positive RA.         No concomitant medication were reported. Patient stated that after vaccination all positive RA numbers went down. All RA manifestations went away. Lab test Predictors of RA were completely gone. The patient had minimal arthritis symptoms from time to time and it goes away without using any medications. No treatment information were provided..   This case was linked to MOD-2022-564583, MOD-2022-564650, MOD-2022-564658 (Patient Link).
Received Varivax vaccine on 09/28/99 and was Dx with chickenpox 6/1/04.
Body Aches Swollen Arm at injection Headaches Chills High Fever for 24 hours
moderna covid vax 3/3 and 3/31/21 art graft thrombus dx'd 5 Jul 2021 at aortobiiliac graft required surgery bypass w/ resection of occluded graft, then, eliqus and ASA and smoking cessation
vaccine reaction; This case was reported by a consumer via interactive digital media and described the occurrence of adverse reaction in a patient who received Flu unspecified (Influenza vaccine) for prophylaxis.   On an unknown date, the patient received Influenza vaccine at an unknown dose. On an unknown date, less than a year after receiving Influenza vaccine, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown.   It was unknown if the reporter considered the adverse reaction to be related to Influenza vaccine.  Additional details were provided as follows: The age at vaccination was not reported. Two years before the reporting date (in 2017), the patient had flu vaccine and had a reaction to it so refused one flu vaccine, last year.
3 days later, had red and swollen upper arm; hot; 10cm X 8cm; not very tender. It's ok.
Chest pain; Heaviness in chest; Fever; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pain), CHEST DISCOMFORT (Heaviness in chest) and PYREXIA (Fever) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003C21A and 003C21A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included LEVOTHYROXINE for an unknown indication.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-May-2021, the patient experienced CHEST PAIN (Chest pain) and CHEST DISCOMFORT (Heaviness in chest). 04-May-2021, the patient experienced PYREXIA (Fever). At the time of the report, CHEST PAIN (Chest pain), CHEST DISCOMFORT (Heaviness in chest) and PYREXIA (Fever) had resolved.            Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.     This case was linked to MOD-2021-090437 (Patient Link).
This spontaneous report was received from a healthcare professional and refers to a currently 12 months old, male patient. The patient's medical history and concurrent conditions were not reported. On 12-NOV-2015, the patient was vaccinated with an improperly stored dose of VARIVAX (Merck) lot # L008270 with expiration date 11-MAR-2017 (dose, and route of administration were not provided). No concomitant medications were reported. No adverse effects were reported. This is one of several reports received from the same source. Additional information is not expected as all schedule follow up information was received.
Starting at 03:00 pm,  I felt malaise, slight chills, and achy joints and muscles. I took a tylenol  then and later around 6:oo pm.  I Awakened at 10:00 pm with heart pounding, difficulty breathing, malaise, muscle pains especially left arm.  My pulse rate was in the 90's. Chest felt like someone was sitting on chest, didn't feel like chest tightness from asthma. I took a tylenol  and fell asleep shortly after.  When I awoke in the morning, I felt better, just had the malaise and achiness during the day until around 3:00 pm and then it just gradually went away. So in summary, the symptoms lasted 12 hours with the one severe episode that lasted 30min - hour unitl I feel asleep.
This spontaneous report as received from a physician refers to a male patient of unknown age. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (dose, route, lot number not reported). No other co-suspects were reported. No concomitant medications were reported. On an unknown date, after administering ZOSTAVAX, the patient developed a rash and several spots on different areas of the body the patient complained about. No treatment information was reported. At the time of the report the patient's outcome was unknown. The patient sought medical attention, came back for a doctor visit. The relatedness for adverse events was not reported for ZOSTAVAX. Additional information is not expected.
acute adrenal crisis; A spontaneous report was received from a Physician regarding his son who received second dose of Moderna Covid-19 vaccine and have experienced acute adrenal crisis.  The patient's medical history was not provided. His concomitant medications were not provided. No information on allergies.   On 11-FEB-2021, prior to the onset of events, the patient received second of two planned doses of Covid-19 vaccine for the prophylaxis of Covid-19 infection. Patient lives in a group home. On an unspecified date, he seemed to be confused, disoriented and unable to talk. Father met him at Emergency department where the patient had an acute adrenal crisis , and after ruling out stroke ,he was diagnosed with Addison's disease(loss of adrenal function). He was admitted and discharged after two days. Post discharge, he seemed totally normal.  Action taken with the vaccine is not applicable as the patient received both the doses.  The outcome of the event acute adrenal crisis is considered recovered at the time of report.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.  Further information has been requested.
The patient reports worsening shortness of breath, cough, and diarrhea over the past week. She reports testing positive for COVID-19 on 11/8/21. Per EMS report, the patient had an O2 sat of 80% on her baseline 2 L O2 by nasal cannula. The patient was increased to 4 L O2 by nasal cannula and had improvement of O2 sat. Patient is being admitted for increased O2 needs secondary to COVID-19. The patient has received dexamethasone and Actemra.
She also has herpes and never has experienced an outbreak since getting the Pfizer-BioNTech COVID-19 vaccine; This is a spontaneous report from a contactable consumer or other non hcp (Patient). This consumer (patient) reported for herself.  A 50-years-old female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: not reported), via an unspecified route of administration on an unspecified date as unknown, single dose for covid-19 immunisation. Medical history of patient included herpes. The patient's concomitant medications were not reported. On an unknown date, the patient experienced she also has herpes and never has experienced an outbreak since getting the pfizer-biontech covid-19 vaccine. It was reported that she explained this group includes people with STD that have experienced positive reaction to the COVID-19 vaccine. She explained this individual called Pfizer earlier and reported never having an outbreak of her herpes since being vaccinated and encouraged Pfizer to make a study on such population. Caller explained she doesn't had the individual's gender since they are using false usernames. She added she also had herpes and never has experienced an outbreak since getting the Pfizer-BioNTech COVID-19 vaccine. She specified not having any medical inquiries. The outcome of event was unknown.  Information about batch/lot number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021687833 same reporter/drug/AE, different patient;US-PFIZER INC-2021694629 Same reporter/ drug/ AE, different patient
Heavy chest pressure and fatigue.   Developed rash on upper abdomen.  Contusion on left palm - blood bump.
Nausea, vomiting, fever of 101.2, headache, chills, muscle tenderness, fatigue, increase heart rate 103. Increase respiration. 09/04/2021-09/05/2021
Pt seen in ER on 22JUL91 for vomiting, diarrhea, pimple-like rash; Given Atarax syrup, Donnagel & Elocon cream for rash; ER MD stated it was an allergic rxn to immun;
Fever 100.8; Nausea with vomitting; Nausea with vomitting; Loss of appetite; Fatigue; Chills; Headache; This is a spontaneous report from a contactable other HCP. This female other HCP (patient) reported for herself that,  A 68-years-old non pregnant female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot Number: EW0172), dose 2 via an unspecified route of administration, administered in arm right on 27Apr2021 10:30 as dose 2, single for covid-19 immunisation (age at the vaccination 68 years old). Historical vaccine, the patient took first dose bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: EW0150), dose 1 via an unspecified route of administration, administered in arm right on 06Apr2021 10:30 as dose 1, single for covid-19 immunisation. Medical history included, Almost all antibiotics, Aspirin, Motrin, Almost all opoids, mushrooms and structured information severe osteoporosis, IBS, Acid Reflex, chronic Back Pain, CRPS-RSD, borderline Asthma from an unknown date and unknown if ongoing. Concomitant medication(s) included calciferol [ergocalciferol] (CALCIFEROL [ERGOCALCIFEROL]) taken for an unspecified indication, start and stop date were not reported; macrogol 3350 (MIRALAX) taken for an unspecified indication, start and stop date were not reported; paracetamol (TYLENOL) taken for an unspecified indication, start and stop date were not reported. The patient previously took bnt162b2 for covid-19 immunisation, aspirin (e.c.) and experienced drug hypersensitivity, motrin [ibuprofen] and experienced drug hypersensitivity. It was reported on 27Apr2021 19:30, patient experienced fever 100.8, nausea with vomiting, loss of appetite, fatigue, chills and headache. No treatment was received. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Lab data included, on 27Apr2021, fever 100.8. The patient had not been tested for COVID since the vaccination. The outcome for the events was recovering.  No follow-up attempts are needed. No further information is expected.
Five days after vaccine dose I started with axillary swelling on left side. Then I started having progressive redness, swelling and itching at injection site. By day 8 (after vaccine) I had a 4x4? hard lump at injection site spreading from my deltoid to my elbow. Numbness and tingling in hand. Swollen, palpable lymph nodes in left armpit. Treated with Keflex and Zyrtec. Symptoms improved after 2 days on antibiotics and resolved after 7 days with the exception of tenderness and soreness which is ongoing. There was question if the vaccine was given too low and how much was in deltoid.
On 6/12/01, the vaccinee received his 5th 0.5cc dose of Infanrix, his 4th .5cc SC dose of IPOL and his 2nd 0.5cc SC dose of MMR. On 6/13/01, the vaccinee experienced a "low-grade" site reaction which included redness (2" in diameter), "a small amount" of swelling, and warm to touch. Ibuprofen 1 1/2 teaspoons every 6 hours orally for swelling and pain as needed (6/13/01 to 6/14/01) and cold pack helped to reduce swelling and discomfort. These symptoms then subsided day 2-3 after injection, with no subsequent problems reported since. Infanrix was discontinued. The reporter stated that the adverse events were mild in severity and were related to Infanrix. As of 8/16/01, the adverse events had resolved.
Fatigue, 12+ hours after vaccination  Tachycardia, heart rate 130-140 resting,, onset 12+ hours after vaccination Nausea, onset 1 hour after vaccination  Headache, onset 1 hour after vaccination
This spontaneous report was received from a nurse, concerning a patient of an unknown age and gender. There were no concurrent conditions, medical history, drug reactions or allergies or concomitant medications reported. On an unspecified date, the patient was vaccinated with a dose of VARIVAX injection (dose, frequency and route were not reported; indication: prophylaxis) lot # H018758 with expiration date of 11-OCT-2014, instead of intended M-M-R-II dose.  No product quality complaint (PQC) was involved. No adverse effects were reported. Additional information is not expected, as no consent to contact the reporter was granted.
Tinnitus, on going since the night after the 2nd vaccine.  High pitched ringing in ears.  Volume varies.
Apx. 4-5 hours after vaccine, employee states began having fever of 104. F. Upon awakening following morning fever was gone and noticed 2 blisters apx 1" away on each side injection site. Blisters then scabbed apx. Sunday 12-27-09.
Patient responded well to first dose of COVID vaccination, but after second (administered 4/30/2021) developed persisting nausea x5.5 weeks, intermittent diarrhea and vomiting. She has been afebrile. One ED visit for IV fluids due to dehydration, but has been tolerating fluids since then, minimal food intake.
Information has been received from a registered nurse concerning a 20 year old female who on 29-OCT-2007 was vaccinated with Gardasil (dose and route of therapy not reported).  Concomitant therapy included birth control pills (unspecified).  On 29-OCT-2007 the patient developed contact dermatitis after being given Gardasil.  The patient was treated with methylprednisolone (MEDROL DOSEPAK).  No other information was reported.  Additional information has been requested. Follow-up received 04/16/2008 reported that the patient had a whole body rash and erythematous pruritic macules after receiving the second dose of GARDASIL on 11-JAN-2008. The patient recovered on 28-JAN-2008.
Within a half hour of vaccination, site had a bruise. By the next morning, May 29, site still appeared bruised, but redness was beginning. By May 30, site was extremely red, raised, swollen & painful. By May 31, area welt had grown to about 3" x 2" big, was bright red, raised, swollen, rash was beginning around area, hot to touch with pain going down to elbow & going up my neck, & I had a headache. My daughter who is a Licensed Vocational Nurse, her boyfriend who is a Registered Nurse, and my older daughter who is a Certified Nursing Assistant all insisted that I go to the ER to be treated & seen for the reaction to the vaccination because my symptoms seemed to be getting worse. On May 31, I went to the ER, where I was examined by 2 doctors. One doctor decided that perhaps I was having an infection (?) so he prescribed, & I am still taking the antibiotic, K-Flex, which really does not seem to be doing anything. The area is greatly improved, although there is still some pain at the site, but I believe it was more of an allergic reaction than an infection and just time has improved it.
Patient may have received an undiluted 2nd dose of Pediatric vaccine.  No adverse events at this time of reporting.
Swelling, erythema, at injection site with temperature of 99F, nausea, vomiting, and body aches. Symptoms resolved after 3 days.
This spontaneous report as received from a nurse refers to unspecified number of patients of unknown age and gender. Pertinent medical history was unknown. Since 19-FEB-2015 improperly stored PROQUAD (Merck) (dose, route of administration, anatomical location and lot number was unknown) were administered to unspecified number of patients. Concomitant medications were unspecified by reporter. No adverse effects were noted. The outcome of the events was unknown. This case is linked to the case# 1502USA010390 via same reporter link. Additional information has been requested.
My arm was sore and I was tired the night after getting the vaccine. The next morning, I still had fatigue and are soreness, but around 10:30 am I began feeling nauseous  and I vomited around 11. I still felt tired, nauseous, and  sore the next day.